Experience of bone tumors treatment in the Kyrgyz National Center of Oncology and Hematology
Abstract
Among malignant tumors, tumor lesions of the skeleton are relatively rare. However, most often disease affects young people of active age. Skeletal tumors often lead to disability of the patient. Thus, bone tumors are not just purely medical problem, but also a social one. Research of effective treatment for this group of patients remains an urgent task among orthopedic oncology.
About the Authors
A. T. Alymkulov
National Center of Oncology and Hematology of the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan
Kyrgyzstan
A. A. Babalaev
National Center of Oncology and Hematology of the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan
Kyrgyzstan
K. K. Djunushaliev
National Center of Oncology and Hematology of the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan
Kyrgyzstan
T. A. Abdyldaev
National Center of Oncology and Hematology of the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan
Kyrgyzstan
A. M. Beyshembaev
National Center of Oncology and Hematology of the Ministry of Health of the Kyrgyz Republic
Kyrgyzstan
Kyrgyzstan
References
1. Заридзе Д.Г. Архив патологии. 2003, № 2, с. 53-61.
2. Ганцев Ш.Х. Онкология. М., 2004, с. 433-464.
3. Давыдов М.И. Энциклопедия клинической онкологии. М., 2004, с. 60-89.
4. Liu F., Zhang Q., Zhu D. et al. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcomas. Medicine (Baltimore). 2015, v. 94 (36), e1462.
5. NCI. SEER Cancer Statistics Review, 1975–2008. National Cancer Institute. 2011. http://ser.cancer.gov/csr/1975_2008/.
6. Fletcher C.D.M., Bridge J.A., Hogendoorn P.C.W. et al. Pathology and Genetics of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC Press. 2013.
7. Rehan N., Bieling P., Winkler P. et al. The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy. Klin. Padiatr. 1993, v. 205, p. 200-209. (In German).
8. Bielack S.S., Kempf-Bielack B., Delling G. et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 2002, v. 20, p. 776-790.
9. Ferrari S., Bertoni F., Mercuri M., Picci P., Giacomini S., Longhi A., Bacci G. Predictive factors of disease-free survival for nonmetastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann. Oncol. 2001, v. 12, p. 1145-1150.
10. Pochanugool L., Subhadharaphandou T., Dhanachai M., HathiratP., Sangthawan D., Pirabul R., Onsanit S., Pornpipatpong N. Prognostic factors among 130 patients with osteosarcoma. Clin. Orthop. Relat. Res. 1997, v. 345, p. 206-214.
11. Bacci G., LonghiA., BertoniF., BacchiniP., RuggeriP., Versari M., Picci P. Primary high-grade osteosarcoma: comparison between preadolescent and older patients. J. Pediatr. Hematol. Oncol. 2005, v. 27, p. 129-134.
12. Алиев М.Д., Сушенцов Е.А. Современная онкоортопедия. Саркомы костей, мягких тканей и опухоли кожи. 2012, № 4, с. 3-10.
Review
For citations:
Alymkulov A.T., Babalaev A.A., Djunushaliev K.K., Abdyldaev T.A., Beyshembaev A.M. Experience of bone tumors treatment in the Kyrgyz National Center of Oncology and Hematology. Bone and soft tissue sarcomas, tumors of the skin. 2017;(3):21-27. (In Russ.)
Views:
148
Email this article 
